Samrat Pharma — 360° view

Samrat Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹66 crore and net profit of ₹0.44 crore for the September 2026 quarter.

Samrat Pharma (BSE: SAMRATPH) closed at ₹223.30 on 20 Nov 2026, down 18.6% over the past year. Its market capitalisation is ₹69 crore.

Share price
₹223.30 (20 Nov 2026)
Market cap
₹69 Cr (20 Nov 2026)
Revenue
₹66 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
-2.88% (FY26)
ROE
-5.19% (FY26)
Book value
₹225 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹298.00 / ₹190.00 (20 Nov 2026)
1-year return
-18.6% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: SAMRATPH

Incorporated in 1992, Samrat Pharmachem Ltd does manufacturing and selling of chemicals

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.